14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Apr 29, 2024 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Apr 25, 2024 Buy 37 752 Pershing Edward Series D-1 Convertible Preferred Stock
Apr 25, 2024 Sell 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Apr 19, 2024 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Apr 11, 2024 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Apr 06, 2024 Buy 47 190 Pershing Edward Series D-1 Convertible Preferred Stock
Apr 06, 2024 Sell 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Mar 26, 2024 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Mar 21, 2024 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Mar 17, 2024 Buy 47 190 Pershing Edward Series D-1 Convertible Preferred Stock
Mar 17, 2024 Sell 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Feb 28, 2024 Sell 0 Raines Heather 8% Unsecured Convertible Promissory Note due 2022
Feb 27, 2024 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Feb 27, 2024 Buy 37 744 Pershing Edward Series D-1 Convertible Preferred Stock
Feb 27, 2024 Sell 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Feb 17, 2024 Buy 47 180 Pershing Edward Series D-1 Convertible Preferred Stock
Feb 17, 2024 Sell 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Feb 15, 2024 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Feb 02, 2024 Sell 0 Raines Heather 8% Unsecured Convertible Promissory Note due 2022
Jan 30, 2024 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Jan 26, 2024 Buy 47 180 Pershing Edward Series D-1 Convertible Preferred Stock
Jan 26, 2024 Sell 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Jan 12, 2024 Buy 47 180 Pershing Edward Series D-1 Convertible Preferred Stock
Jan 12, 2024 Sell 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Dec 28, 2023 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Dec 22, 2023 Buy 9 440 Pershing Edward Series D-1 Convertible Preferred Stock
Dec 22, 2023 Sell 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Dec 19, 2023 Buy 37 760 Pershing Edward Series D-1 Convertible Preferred Stock
Dec 19, 2023 Sell 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Dec 02, 2023 Buy 56 628 Pershing Edward Series D-1 Convertible Preferred Stock
Dec 02, 2023 Sell 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Nov 29, 2023 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Nov 15, 2023 Buy 9 440 Pershing Edward Series D-1 Convertible Preferred Stock
Nov 15, 2023 Sell 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Nov 08, 2023 Buy 37 744 Pershing Edward Series D-1 Convertible Preferred Stock
Nov 08, 2023 Sell 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Nov 01, 2023 Buy 13 216 Pershing Edward Series D-1 Convertible Preferred Stock
Nov 01, 2023 Sell 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Oct 27, 2023 Buy 2 832 Pershing Edward Series D-1 Convertible Preferred Stock
Oct 27, 2023 Sell 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Oct 14, 2023 Buy 18 888 Pershing Edward Series D-1 Convertible Preferred Stock
Oct 14, 2023 Sell 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Oct 03, 2023 Buy 19 311 Pershing Edward Series D-1 Convertible Preferred Stock
Sep 30, 2023 Buy 41 518 Pershing Edward Series D-1 Convertible Preferred Stock
Sep 30, 2023 Sell 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Sep 23, 2023 Buy 28 320 Pershing Edward Series D-1 Convertible Preferred Stock
Sep 01, 2023 Buy 37 760 Pershing Edward Series D-1 Convertible Preferred Stock
Aug 11, 2023 Buy 0 Morris Jeffrey Allen 8% Secured Convertible Promissory Note
Aug 03, 2023 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Jul 28, 2023 Buy 28 326 Pershing Edward Series D-1 Convertible Preferred Stock
Jul 28, 2023 Sell 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Jul 24, 2023 Buy 56 639 Pershing Edward Series D-1 Convertible Preferred Stock
Jul 24, 2023 Sell 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Jul 20, 2023 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Jun 30, 2023 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Jun 15, 2023 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
May 26, 2023 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
May 12, 2023 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
May 08, 2023 Buy 188 757 Morris Jeffrey Allen Series D-1 Convertible Preferred Stock
May 05, 2023 Buy 0 Morris Jeffrey Allen 8% Secured Convertible Promissory Note
Apr 25, 2023 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Apr 06, 2023 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Mar 27, 2023 Buy 0 Morris Jeffrey Allen Common Stock
Mar 27, 2023 Buy 0 Morris Jeffrey Allen Series D-1 Convertible Preferred Stock
Mar 17, 2023 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Feb 17, 2023 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Jan 26, 2023 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Jan 12, 2023 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Dec 02, 2022 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note due 2023
Nov 15, 2022 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note due 2023
Nov 08, 2022 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note due 2023
Nov 01, 2022 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note due 2023
Oct 27, 2022 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note due 2023
Sep 16, 2022 Buy 11 416 262 Rodrigues Dominic Series D Convertible Preferred Stock
Sep 01, 2022 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note
Jul 15, 2022 Buy 0 Pershing Edward 8% Unsecured Convertible Promissory Note due 2023
Aug 16, 2021 Buy 0 Raines Heather 8% Unsecured Convertible Promissory Note due 2022
Jun 20, 2021 Buy 20 289 Raines Heather Series D-1 Convertible Preferred Stock
Jun 20, 2021 Sell 0 Raines Heather 8% Secured Convertible Promissory Notes due 2021
Jun 20, 2021 Buy 41 323 Bailey Webster Series D-1 Convertible Preferred Stock
Jun 20, 2021 Sell 0 Bailey Webster 8% Secured Convertible Promissory Notes due 2021
Jun 20, 2021 Buy 478 926 Pershing Edward Series D-1 Convertible Preferred Stock
Jun 20, 2021 Sell 0 Pershing Edward 8% Secured Convertible Promissory Notes due 2021
Jun 20, 2021 Buy 1 393 276 Wachter Eric Phd Series D-1 Convertible Preferred Stock
Jun 20, 2021 Sell 0 Wachter Eric Phd 8% Secured Convertible Promissory Notes due 2021
Jun 20, 2021 Buy 38 473 Horowitz Bruce Series D-1 Convertible Preferred Stock
Jun 20, 2021 Sell 0 Horowitz Bruce 8% Secured Convertible Promissory Notes due 2021
Jun 17, 2021 Buy 0 Raines Heather 8% Secured Convertible Promissory Notes due 2021
Jun 17, 2021 Buy 0 Bailey Webster 8% Secured Convertible Promissory Notes due 2021
Jun 17, 2021 Buy 0 Pershing Edward 8% Secured Convertible Promissory Notes due 2021
Jun 17, 2021 Buy 0 Wachter Eric Phd 8% Secured Convertible Promissory Notes due 2021
Jun 17, 2021 Buy 0 Horowitz Bruce 8% Secured Convertible Promissory Notes due 2021
Nov 10, 2020 Buy 50 000 Raines Heather Common Stock
Nov 10, 2020 Buy 100 000 Lacy John Iii Common Stock
Nov 10, 2020 Buy 100 000 Lacy John Iii Stock Options (Right to Buy)
Nov 10, 2020 Buy 2 425 000 Horowitz Bruce Stock Options (Right to Buy)
Nov 10, 2020 Buy 800 000 Horowitz Bruce Common Stock
Jul 13, 2020 Buy 0 Bailey Webster Common Stock
Jul 13, 2020 Buy 0 Bailey Webster Common Stock
Apr 03, 2017 Sell 0 Horowitz Bruce Common Stock
INSIDER POWER
99.445
Last 100 transactions
Buy: 17 761 544 | Sell: 0 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 99.445.

In total, the insiders bought 17 761 544 and sold 0 PVCT shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Provectus Pharmaceuticals, Inc

Provectus Pharmaceuticals Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. It develops PV-10, an investigational autolytic cancer immunotherapy for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, including hepatocellular carcinoma; colorectal cancer metastatic to the liver; neuroendocrine tumors metastatic to the liver; uveal melanoma metastati... PVCT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT